Eiichiro Noguchi
Impact in
-
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
-
- Thyroid Cancer Diagnosis and Treatment
Papers in
- Oncology 5
- HER2/EGFR in Cancer Research 2
-
- Cancer and Skin Lesions 4
- Co-authors
- Xiaoyan Kang (1 shared paper)Yoichiro Homma (1 shared paper)Xiaojing Ma (1 shared paper)Mihai G. Netea (1 shared paper)Takahiro Okamoto (5 shared papers)Kiyomi Horiuchi (3 shared papers)Wenwu Dong (2 shared papers)Akiko Sakamoto (1 shared paper)
- Journals
- Annals of Nuclear Medicine (1 paper)ESMO Open (1 paper)Nature Immunology (1 paper)Annals of Oncology (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Eiichiro Noguchi
12 papers receiving 334 citations
Peers
Comparison fields: 5 of 61
- Immunology 85
- Endocrinology, Diabetes and Metabolism 62
- Genetics 85
- Hepatology 12
- Molecular Biology 110
Countries citing papers authored by Eiichiro Noguchi
This map shows the geographic impact of Eiichiro Noguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichiro Noguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichiro Noguchi more than expected).
Fields of papers citing papers by Eiichiro Noguchi
This network shows the impact of papers produced by Eiichiro Noguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichiro Noguchi. The network helps show where Eiichiro Noguchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Eiichiro Noguchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 150 | |
| 2 | 2019 | 87 | |
| 3 | 1994 | 37 | |
| 4 | 2015 | 30 | |
| 5 | 2014 | 7 | |
| 6 | 2016 | 7 | |
| 7 | 2023 | 5 | |
| 8 | 2021 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2019 | 2 | |
| 11 | 2017 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2018 | 0 | |
| 14 | 2025 | 0 | |
| 15 | 2023 | 0 |
About Eiichiro Noguchi
Eiichiro Noguchi is a scholar working on Oncology, Dermatology, Surgery, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 15 papers that have together received 338 indexed citations. Recurring topics across this work include Cancer and Skin Lesions (4 papers), Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), BRCA gene mutations in cancer (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Breast Lesions and Carcinomas (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Immunology (85 citations), Endocrinology, Diabetes and Metabolism (62 citations), Genetics (85 citations), Hepatology (12 citations) and Molecular Biology (110 citations). Eiichiro Noguchi has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Xiaoyan Kang, Yoichiro Homma, Xiaojing Ma, Mihai G. Netea, Takahiro Okamoto, Kiyomi Horiuchi, Wenwu Dong, Akiko Sakamoto, Shingo Kameoka and Makio Kobayashi. Their work appears in journals such as Annals of Nuclear Medicine, ESMO Open, Nature Immunology, Annals of Oncology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.